NO851774L - Fremgangsmaate for fremstilling av en 2-oksindol-1-karboksamid-forbindelse. - Google Patents

Fremgangsmaate for fremstilling av en 2-oksindol-1-karboksamid-forbindelse.

Info

Publication number
NO851774L
NO851774L NO851774A NO851774A NO851774L NO 851774 L NO851774 L NO 851774L NO 851774 A NO851774 A NO 851774A NO 851774 A NO851774 A NO 851774A NO 851774 L NO851774 L NO 851774L
Authority
NO
Norway
Prior art keywords
ocsindol
procedure
preparation
carboxamide compound
carboxamide
Prior art date
Application number
NO851774A
Other languages
English (en)
Other versions
NO163132B (no
NO163132C (no
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO851774L publication Critical patent/NO851774L/no
Publication of NO163132B publication Critical patent/NO163132B/no
Publication of NO163132C publication Critical patent/NO163132C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO851774A 1984-05-04 1985-05-03 Analogifremgangsm te for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav. NO163132C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (3)

Publication Number Publication Date
NO851774L true NO851774L (no) 1985-11-05
NO163132B NO163132B (no) 1990-01-02
NO163132C NO163132C (no) 1990-04-11

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851774A NO163132C (no) 1984-05-04 1985-05-03 Analogifremgangsm te for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav.

Country Status (25)

Country Link
JP (1) JPS60243068A (no)
KR (1) KR870000497B1 (no)
AR (1) AR241159A1 (no)
BG (2) BG60208B2 (no)
CS (1) CS252828B2 (no)
DD (1) DD232916A5 (no)
EG (1) EG17193A (no)
ES (2) ES8609248A1 (no)
FI (1) FI80016C (no)
HU (1) HU196057B (no)
IE (1) IE851103L (no)
IN (1) IN161509B (no)
MA (1) MA20424A1 (no)
MW (1) MW1685A1 (no)
MX (1) MX5839A (no)
NO (1) NO163132C (no)
OA (1) OA08098A (no)
PL (2) PL145416B1 (no)
PT (1) PT80375B (no)
RO (2) RO94455B (no)
RU (1) RU2017729C1 (no)
SU (1) SU1468413A3 (no)
YU (1) YU44998B (no)
ZA (1) ZA853324B (no)
ZW (1) ZW7885A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
CS252828B2 (en) 1987-10-15
MW1685A1 (en) 1986-09-10
PL257892A1 (en) 1986-10-07
RO91141B (ro) 1987-07-03
IN161509B (no) 1987-12-19
FI851756L (fi) 1985-11-05
ES551275A0 (es) 1987-07-16
JPS60243068A (ja) 1985-12-03
NO163132B (no) 1990-01-02
ES8609248A1 (es) 1986-07-16
YU73085A (en) 1988-04-30
BG60207B2 (en) 1993-12-30
RU2017729C1 (ru) 1994-08-15
HUT37754A (en) 1986-02-28
CS320285A2 (en) 1987-03-12
RO91141A (ro) 1987-06-30
IE851103L (en) 1985-11-04
MX5839A (es) 1993-11-01
MA20424A1 (fr) 1985-12-31
PL145416B1 (en) 1988-09-30
AR241159A1 (es) 1991-12-30
FI80016B (fi) 1989-12-29
ES8707182A1 (es) 1987-07-16
YU44998B (en) 1991-06-30
NO163132C (no) 1990-04-11
KR870000497B1 (ko) 1987-03-12
RO94455A (ro) 1988-06-30
KR850008154A (ko) 1985-12-13
ZA853324B (en) 1986-12-30
ZW7885A1 (en) 1985-07-24
DD232916A5 (de) 1986-02-12
PT80375B (pt) 1987-09-30
BG60208B2 (en) 1993-12-30
ES542813A0 (es) 1986-07-16
AR241159A2 (es) 1991-12-30
RO94455B (ro) 1988-07-01
PT80375A (en) 1985-05-01
EG17193A (en) 1990-08-30
FI80016C (fi) 1990-04-10
SU1468413A3 (ru) 1989-03-23
PL253203A1 (en) 1986-06-17
OA08098A (fr) 1987-03-31
HU196057B (en) 1988-09-28
JPH0335315B2 (no) 1991-05-27
PL147508B1 (en) 1989-06-30
FI851756A0 (fi) 1985-05-03

Similar Documents

Publication Publication Date Title
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
FI852516L (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
ES542428A0 (es) Procedimiento de preparacion de una olefina polisulfurada.
NO855048L (no) Fremgangsmaate for fremstilling av et stabilisert nicorandil-preparat.
NO851524L (no) Fremgangsmaate for fremstilling av fenetanolamin-forbindelser
NO163402C (no) Fremgangsmaate for fremstilling av acylerte diketonforbindelser.
ES539954A0 (es) Procedimiento de preparacion de un derivado de ciano-2-ben- cimidazol
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO164772C (no) Fremgangsmaate for fremstilling av cefalosporinderivater.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
ES537947A0 (es) Procedimiento de preparacion de un derivado de piracina.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO161911C (no) Fremgangsmaate for fremstilling av sulfonater.
NO162816C (no) Fremgangsmaate for fremstilling av et dialkanolyksybenzylidendialkanoat.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
ES551275A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
NO900285D0 (no) Fremgangsmaate for fremstilling av en pyridobenzodiazepinforbindelse.
RO88740A2 (ro) Procedeu pentru prepararea a n,n-dimetilaminopropilmetacrilamidei
NO903304L (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903305D0 (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Legal Events

Date Code Title Description
MK1K Patent expired